Three regulatory compliant test systems show no signs of MDMA-related genotoxicity
Keyword(s):
3,4 Methylenedioxymethamphetamine (MDMA)-assisted therapy has been recently found to be highly effective for treatment of posttraumatic stress disorder (PTSD). Previous studies have been inconclusive in elucidating potential MDMA genotoxicity. We performed three regulatory compliant studies to investigate the potential of genotoxic effects of MDMA treatment in humans: (1) an in vitro bacterial reverse mutation (Ames) assay, (2) an in vitro chromosome aberration test in Chinese hamster ovary cells, and (3) an in vivo micronucleus study in male Sprague Dawley rats. MDMA was found to not have genotoxic effects in any of the assays at or above clinically relevant concentrations.
2012 ◽
Vol 31
(6)
◽
pp. 584-594
◽
1993 ◽
Vol 90
(10)
◽
pp. 4611-4615
◽
1985 ◽
Vol 101
(3)
◽
pp. 755-765
◽
1977 ◽
Vol 73
(3)
◽
pp. 601-615
◽
Keyword(s):
2004 ◽
Vol 42
(8)
◽
pp. 1245-1249
◽
1992 ◽
Vol 8
(6)
◽
pp. 369-376
◽
1997 ◽
Vol 29
(4)
◽
pp. 386-393
◽
Keyword(s):
2005 ◽
Vol 16
(11)
◽
pp. 5087-5093
◽